News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Beijing Med-Pharm Corp. (BJGP.PK) Receives MOFCOM Approval to Acquire Interest in Shanghai Rongheng Pharmaceutical Co., Ltd.



2/1/2008 8:55:46 AM

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Beijing Med-Pharm Corporation (NASDAQ:BJGP) (“Beijing Med-Pharm” or the “Company”), one of China’s leading pharmaceutical, marketing and distribution companies, today announced that the Ministry of Commerce (MOFCOM) of the People's Republic of China has approved its acquisition of 63.3 percent of Shanghai Rongheng Pharmaceuticals Co. Ltd. (“Rongheng”). Beijing Med-Pharm expects to close the transaction in the first quarter of 2008.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES